ArticleCureus2026
Changing Patterns of Cutaneous Melanoma Mortality in Brazil: A Nationwide Time-Series Analysis (2000-2024).
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCutaneous melanoma accounts for most deaths from skin cancer, and mortality is consistently higher in men than in women. National trends in Brazil have not been characterized using population estimates rebased to the 2022 Census. MATERIALS AND
methodsWe conducted a nationwide ecological time-series study of deaths from cutaneous melanoma (ICD-10 C43) recorded in Brazil's Mortality Information System from 2000 to 2024. Population denominators were obtained from the 2024 revision of the Brazilian Institute of Geography and Statistics projections, rebased to the 2022 Census. Rates were directly age-standardized to the 2022 Brazilian population; 95% confidence intervals (CIs) were estimated using the Fay-Feuer gamma method, a standard approach for deriving exact confidence limits for standardized rates from count data. National and subgroup trends were assessed using segmented log-linear regression, which identifies the calendar years in which a trend changes direction. Differences by sex, region, and age group were examined using age-adjusted negative binomial models with population offsets, which compare death rates between groups of different population sizes. The sex interaction was prespecified as a secondary, exploratory comparison and was not adjusted for multiple testing. The COVID-19 period was assessed using an interrupted time-series model with 2020 specified a priori.
resultsBetween 2000 and 2024, 38,346 deaths were attributed to cutaneous melanoma. Annual deaths increased from 1,027 to 2,031, whereas the age-standardized rate was essentially unchanged, from 0.91 to 0.92 per 100,000 population. Mortality increased by 0.83% per year (95% CI 0.52 to 1.14) until 2016 and declined by 1.12% per year (-1.69 to -0.54) thereafter. The full-period average annual percentage change (AAPC) was 0.17% (-0.01 to 0.36; p = 0.065). Men had higher rates throughout. Sex-specific segmented models showed an increase followed by a decline in men and an overall stable trend in women. An exploratory, non-multiplicity-adjusted interaction offered limited and inconsistent evidence of a more favorable trajectory in women than in men (p = 0.037). Mortality declined in all groups younger than 60 years and increased overall among adults aged 60 years or older, although the rise leveled off after 2015. The Southeast declined, the South was stable overall, and the North and Northeast increased from very low initial rates. The pandemic was associated with a one-time 6.60% downward shift in mortality in 2020, without a change in slope. Using population estimates not rebased to the 2022 Census changed the national AAPC from 0.17% (-0.01 to 0.36) to -0.39% (-0.60 to -0.18).
conclusionsThe increasing number of melanoma deaths in Brazil was driven largely by population growth and aging rather than by a sustained increase in age-standardized mortality. A national decline began around 2016, but trends remained heterogeneous by age and region. The material change in the national AAPC after revision of the population denominators demonstrates that denominator vintage is not merely a technical consideration in long-term mortality studies but can materially affect epidemiological conclusions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.